ºÃÉ«ÏÈÉú

CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE

CTSA TL1 Training Program for Pre-doctoral Students in Clinical and Translational Science

 Applications due: March 31, 2017

Kate Breeden closed her eyes as she took a bite, trying to concentrate on the flavors of the food she was sampling. "Well, it's definitely a brownie," she said, "but I have no idea what the mystery ingredient is. Maybe carob instead of chocolate, or dates? But I'm not 100 percent sure to be honest." Breeden was among dozens of women – and a few men – gathered on Feb. 3 to launch Heart Month at ºÃÉ«ÏÈÉú with "Gill Goes Red." The celebration of women's heart health in the hospital's Pavilion A atrium featured giveaways, prizes and simple tips and substitutions to make your diet more heart-healthy.

During a recent trip to Taiwan, Dr. Mark V. Williams, director of the Center for Health Services Research (CHSR), had the opportunity to share his expertise as a hospitalist and researcher with colleagues in Taiwan.

Williams was invited by Dr. Ming-Chin Yang, National Taiwan University’s associate dean of the College of Public Health, and Dr. Nin-Chieh Hsu, a practicing hospitalist in Taiwan, to speak at the Jan. 7 forum of hospital medicine at the first International Conference of Hospital Medicine.

Michele Staton-Tindall grew up in rural Appalachia during a time when people felt so safe they didn’t even lock their doors at night. The ensuing drug epidemic that now ravages her former home has dramatically impacted the lives of the Appalachian people and broken that sense of security.

Dr. Doug Lowy, interim director of the National Cancer Institute, recently visited the University of Kentucky Markey Cancer Center, continuing a dialogue on Kentucky cancer disparities following Lowy's visit to Hazard, Ky. last fall. Much of Lowy's visit focused on research. During the morning session, nine ºÃÉ«ÏÈÉú faculty members gave presentations on major research initiatives and programs at Markey, ranging from efforts in cancer prevention and control to drug development and discovery.

Sales Tax Charges  

If Kentucky State sales tax is charged on goods/services, the sales tax must be charged to a cost center. It cannot be charged to a grant.  

As part of a $3.5 billion enterprise, members of the ºÃÉ«ÏÈÉú community conduct work across a range of disciplines, units, and areas of expertise; but a single idea unites us: Service. You see this idea through our teaching and learning; diversity and inclusion; and through our discovery, research and creativity. You see it through our promotion of health and our deep community engagement. In the Office of Finance and Administration, we aim to mirror that dedication and focus.

In 2015, identical twins Gardner and Jon Wes Adams, then in their mid-20s, both nearly died when their hearts suddenly stopped beating. The incidents happened months apart, but the cause was the same: Brugada syndrome, a rare, congenital heart rhythm disorder.

The College of Medicine has announced its Wethington Award Policy for 2017.

The policy can be found on the COM Research webpage under Support.

Click here to read the full policy.

In accordance with NOT-OD-17-001, (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-17- 001.html), NIH is currently operating under the Fiscal Year 2017 Continuing Appropriations Act, 2017 (H.R. 5325). Therefore, NIH will issue non-competing research grant awards at a level below that indicated on the most recent Notice of Award.

Sponsored Research Administrative Services recently presented a deck of slides with guidance related to booking travel for non-employees.  The document contains a wealth of information including g/l information.  To view the slides, click here. 

This information as well as other documents can be found on the SRAS Useful Information Page.  Click here to view the page. 

Nominate your research mentor for recognition at this year’s CCTS Spring Conference.

Expand your career coaching, leadership and mentoring skills to serve scientists from under-represented groups with this free, interactive program.

Apply Today!

Professional Mentoring Skill Enhancing Diversity (PROMISED)

PROMISED is for mentors at the late Assistant Professor level or above.

Fellows receive...

Face-to-face instruction on how to be a career coachTraining through a series of one-month, online modulesCME/CEU credit and certificates

Apply before February 15, 2017

ATTENTION INVESTIGATORS: FUNDING OPPORTUNITY FOR PILOT PROGRAM

The College of Medicine and Center for Health Services Research
(in collaboration with the VPR, CCTS and ºÃÉ«ÏÈÉú HealthCare)
Call for Applications – Pilot Grant Funding
Value of Innovation to Implementation Program (VI2P)

A multi-site clinical trial led by researchers at the University of Kentucky Center on Drug and Alcohol Research (CDAR) has demonstrated the effectiveness of CAM2038, a potentially transformative buprenorphine therapy for moderate-to-severe opioid use disorders.

Radiation therapy saves countless lives, but in rare cases, it can cause a debilitating, long-term complication when used on the brain. Around three to five percent of patients who receive radiation for brain tumors, or arteriovenous malformations (AVM), develop radiation necrosis, where the brain tissue around the targeted lesion becomes injured and dies. The condition can be disabling, causing severe headaches, nausea and vomiting, cognitive problems and neural dysfunction.

Budgets for commercial, industry-funded clinical trial projects should include a one-time fee of $3,000, listed as "IRB Review Fee". The recent increase in the one-time fee for initial IRB review was implemented as a result of increased administrative and procedural compliance requirements. The current rate remains in line with national standards.

The American College of Cardiology has named Gill Heart Institute's Dr. David J. Moliterno, the new editor-in-chief of JACC: Cardiovascular Interventions. Moliterno is the Jack M. Gill Chair and professor of the Department of Internal Medicine at the University of Kentucky. He is also a member of the interventional cardiology faculty at the ºÃÉ«ÏÈÉú Gill Heart Institute.

A new study by University of Kentucky Markey Cancer Center researchers shows that chloroquine – a drug currently used to treat malaria – may be useful in treating patients with metastatic cancers. Published in Cell Reports, the study showed that chloroquine induced the secretion of the tumor suppressor protein Par-4 in both mouse models and in cancer patients in a clinical trial.

[from the VPR's Office]